Louisiana: Ownership and Oversight
Reduced: board-approved CPA with a no-availability-no-prescribing rule. Louisiana ties all APRN medical diagnosis and prescribing to a board-approved collaborative practice agreement with a physician or dentist, backed by an unusually blunt rule: if the collaborating physician is not reachable, the APRN does not prescribe. Reported 2025 legislation may be changing this landscape; verify before advising.
Who the Statute Actually Covers
- The CPA (La. R.S. 37:913(9); LAC 46:XLVII.4513): a formal written agreement with one or more physicians or dentists covering (a) collaborator availability for consultation/referral, (b) methods of management including clinical practice guidelines, and (c) absence coverage. Submitted to the LSBN with forms and fees for formal approval before prescriptive authority attaches; controlled-substance privileges requested by schedule within the CPA; LSBN notified in writing within 30 days of any change.
- The availability rule: the collaborating physician/dentist must be available physically, by telephone, or by direct telecommunication. Per the LSBN template, if the collaborator is not available, the APRN will not prescribe. The collaborator must be actively practicing, unrestricted, and in good standing with the LSBME.
- Joint management for off-site collaborators (LSBN/LSBME Joint Practice Statement): where the physician's primary site differs from the APRN's and the physician lacks real-time EMR access, the parties must document a joint-management plan (peer review, chart review, QA) at reasonable intervals, expressly including review of the APRN's controlled-substance prescribing.
- Monitor: 2025–26 industry reporting indicates Louisiana enacted an expanded independence pathway; the CPA framework above remains the boards' published rule set — confirm current statute and effective dates with the LSBN before structuring new arrangements.
1. Who Can Own What
| Entity / Path | Who May Own | Key Limits |
|---|---|---|
| Professional entities | Licensee-owned professional corporations/LLCs under Louisiana entity statutes; corporate practice policed through the boards. | Verify combinations with Louisiana counsel. |
| APRN-owned practice | Viable under an approved CPA; LSBN approval means a new practice cannot see its first prescription until paperwork clears. | MAT provision requires the collaborating physician to also be MAT-authorized. |
| PA path | Physician supervision under the LSBME; no ownership lane. | Verify current mechanics. |
| Lay / MSO | Standard structuring; boards police through CPA approval and the joint practice framework. | — |
2. Collaborative and Supervisory Oversight
| Role | Agreement Required | Oversight Mechanics | Path to Independence |
|---|---|---|---|
| PA | LSBME supervision framework; mechanics board-defined. | Verify current agreement requirements and limits. | None. |
| NP / APRN | LSBN-approved CPA before prescribing; clinical practice guidelines; availability rule; 30-day change notices; off-site collaborators documented via joint-management plans including CS prescribing review. | Chart-review mechanics agreement-defined; controlled-substance schedules as approved in the CPA. | None under the published framework; monitor the reported 2025 pathway legislation. |
3. Primary Authorities
- La. R.S. 37:913 (definitions; CPA elements; MAT); LAC 46:XLVII.4513; LSBN CPA template and approval process.
- LSBN/LSBME Joint Practice Statement (availability; joint management; off-site collaboration).
Practical read: Louisiana's availability rule turns collaborator responsiveness into a prescribing switch — an unreachable physician does not just create audit risk, it legally stops the APRN's pen. Louisiana CPAs should name multiple collaborators and spell out coverage chains. And treat the 2025 legislation flag as a live research item.
General education, not legal advice. Verify current statutes, board rules, and opinions before relying on this summary.